EPTIS
BAM Logo

Antibiotics- residues

[Antibiotica- residuen]

EPTIS factsheet 911971 | Last revision 2022-01-07 | URL: https://www.eptis.bam.de/pts911971 https://www.eptis.bam.de/pts911971

PT provider
PT provider Trilogy Europe B.V. Trilogy Europe B.V.
Based in Netherlands
Language(s) English
Remarks
Keywords
Product groups Agriculture
Food and drink
Reference materials
Testing fields Analytical chemistry
Technical details
Test item Tested property Testing method
milk powder, infant milk powder Chlooramphenicol (CAP) ELISA, LC-MS/MS, own method
Gentamycin ELISA, LC-MS/MS, own method
Streptomycin ELISA, LC-MS/MS, own method
Neomycin ELISA, LC-MS/MS, own method
Penicillin ELISA, LC-MS/MS, own method
Erythromycin ELISA, LC-MS/MS, own method
Enrofloxacin ELISA, LC-MS/MS, own method
Ciprofloxacin ELISA, LC-MS/MS, own method
Sulfadiazine ELISA, LC-MS/MS, own method
Tetracycline ELISA, LC-MS/MS, own method
Oxytetracycline ELISA, LC-MS/MS, own method
Aims of the PT scheme
Target group of participants Target groups are global dairy-, food- and feed laboratories
Linked to specific legislation / standards no
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by -
Fees and frequency
Participation fee On request
Regularly operated Yes (1)
Year of first operation 2022
Contact details of the PT provider
Provider Contact person
Trilogy Europe B.V.
Beijerinckweg 18
6827 BN Arnhem
Netherlands

Phone: +31 (0)263031601
Fax:
Web: https://trilogylab.com/ https://trilogylab.com/
Mr. Kees van Putten
Phone: +31 (0)6 30051439
Fax:
Email: kees.vanputten@trilogylab.eu kees.vanputten@trilogylab.eu
If you find any mistakes please contact the responsible EPTIS coordinator in Netherlands, Mr Peter van Otterloo. Mr Peter van Otterloo.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21